US FDA Approval Output Still Not Showing Impact Of Departures

 
• By Derrick Gingery
  
Brand and generic drug approval volume has remained resilient in the face of widespread departures. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from United States